The transfer of VLDL-associated phospholipids to activated platelets depends upon cytosolic phospholipase A2 activity

Journal of Lipid Research

Volumn 48, Issue 7, 2007, Pages 1533-1538

  Ibrahim, Salam ^a,b,c,d,e,f   Calzada, Catherine ^a,b,c,d,e,f   Pruneta Deloche, Valérie ^a,b,c,d,e,f   Lagarde, Michel ^a,b,c,d,e,f   Ponsin, Gabriel ^a,b,c,d,e,f  

^a UNIVERSITÉ DE LYON   (France)

^b INSERM   (France)

^c CEMAGREF   (France)

^d UNIVERSITÉ DE LYON   (France)

^e UNIVERSITÉ LYON 1   (France)

^f HOSPICES CIVILS DE LYON   (France)

Author keywords

Ca2+ independent phospholipase A2; Lipoprotein lipase; Metabolic inhibitors; Thrombin; Very low density lipoprotein

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,2 BIS(2 AMINOPHENOXY)ETHANE N,N,N',N' TETRAACETIC ACID TETRAKIS(ACETOXYMETHYL)ESTER; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BROMOENOL LACTONE; CHELATING AGENT; ESCULETIN; LIPOXYGENASE; METHYL ARACHIDONYL FLUOROPHOSPHONIC ACID; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE INHIBITOR; PHOSPHOLIPID; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID TRANSPORT; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ARACHIDONIC ACIDS; ASPIRIN; BLOOD PLATELETS; CYTOSOL; EGTAZIC ACID; ESTRENES; HUMANS; LIPOPROTEIN LIPASE; LIPOPROTEINS, VLDL; NAPHTHALENES; PHOSPHOLIPASES A; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHOLIPIDS; PHOSPHONIC ACIDS; PLATELET ACTIVATION; PYRONES; PYRROLIDINONES; THROMBIN; UMBELLIFERONES;

EID: 34548179146     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600480-JLR200     Document Type: Article

References (35)

1. Samuelsson, B., M. Goldyne, E. Granström, M. Hamberg, S. Hammarström, and C. Malmsten. 1978. Prostaglandins and thromboxanes. Annu. Rev. Biochem. 47: 997-1029.
2. Clark, J. D., A. R. Schievella, E. A. Nalefski, and L. L. Lin. 1995. Cytosolic phospholipase A2. J. Lipid Mediat. Cell Signal. 12: 83-117.
3. Ha, K. S., and J. H. Exton. 1993. Differential translocation of protein kinase C isozymes by thrombin and platelet-derived growth factor. A possible function for phosphatidylcholine-derived diacylglycerol. J. Biol. Chem. 268: 10534-10539.
4. Hug, H., and T. F. Sarre. 1993. Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J. 291: 329-343.
5. Kent, C. 1995. Eukaryotic phospholipid biosynthesis. Annu. Rev. Biochem. 64: 315-343.
6. Engelmann, B., C. Kögl, R. Kulschar, and B. Schaipp. 1996. Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets. Biochem. J. 315: 781-789.
7. Dobner, P., E. Koller, and B. Engelmann. 1999. Platelet high affinity low density lipoprotein binding and import of lipoprotein derived phospholipids. FEBS Lett. 444: 270-274.
8. Urban, S., S. Zieseniss, M. Werder, H. Hauser, R. Budzinski, and B. Engelmann. 2000. Scavenger receptor B1 transfers major lipoprotein-associated phospholipids into thecells. J. Biol. Chem. 275: 33409-33415.
9. Ibrahim, S., A. Djimet-Baboun, V. Pruneta-Deloche, C. Calzada, M. Lagarde, and G. Ponsin. 2006. Transfer of very low density lipoprotein- associated phospholipids to activated human platelets. J. Lipid Res. 47: 341-348.
10. Jackson, R. L., L. R. McLean, and R. A. Demel. 1987. Mechanism of action of lipoprotein lipase and hepatic triglyceride lipase. Am. Heart J. 113: 551-554.
11. Deckelbaum, R. J., S. Eisenberg, M. Fainaru, Y. Barenholz, and T. Olivecrona. 1979. In vitro production of human low density lipoprotein-like particles: a model for very low density lipoprotein catabolism. J. Biol. Chem. 254: 6079-6087.
12. Glomset, J. A. 1968. The plasma lecithin:cholesterol acyl transferase reaction. J. Lipid Res. 9: 155-167.
13. Patsch, J. M., A. M. Gotto, Jr., T. Olivecrona, and S. Eisenberg. 1978. Formation of high density lipoprotein 2-like particles during lipolysis of very low density lipoproteins in vivo. Proc. Natl. Acad. Sci. USA. 75: 4519-4523.
14. Engelmann, B., B. Schaipp, P. Dobner, M. Stoeckelhuber, C. Kögl, W. Siess, and A. Hermetter. 1998. Platelet agonists enhance the import of phosphatidylethanolamine into human platelets. J. Biol. Chem. 273: 27800-27808.
15. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1354.
16. Elchebly, M., T. Pulcini, B. Porokhov, F. Berthezène, and G. Ponsin. 1996. Multiple abnormalities in the transfer of phospholipids from VLDL and LDL to HDL in non-insulin-dependent diabetes. Eur. J. Clin. Invest. 26: 216-223.
17. Lagarde, M., P. A. Bryon, M. Guichardant, and M. Dechavanne. 1980. A simple and efficient method for platelet isolation from their plasma. Thromb. Res. 17: 581-588.
18. Born, G. V. R. 1962. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194: 927-929.
19. Bleasdale, J. E., N. R. Thakur, R. S. Gremban, G. L. Bundy, F. A. Fitzpatrick, R. J. Smith, and S. Bunting. 1990. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J. Pharmacol. Exp. Ther. 255: 756-768.
20. Vane, J. R., and R. M. Botting. 2003. The mechanism of action of aspirin. Thromb. Res. 110: 255-258.
21. Sekiya, K., H. Okuda, and S. Arichi. 1982. Selective inhibition of platelet lipoxygenase by esculetin. Biochim. Biophys. Acta. 713: 68-72.
22. 2. Annu. Rev. Pharmacol. Toxicol. 39: 175-189.
23. 2 by methyl arachidonyl fluorophosphonate. Biochim. Biophys. Acta. 1302: 55-60.
24. 2 by bromoenol lactone and trifluoromethyl ketones. J. Biol. Chem. 270: 445-450.
25. 2 is phosphorylated in collagen- and thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase. J. Biol. Chem. 270: 25885-25892.
26. Roberts, D. E., A. McNicol, and R. Bose. 2004. Mechanism of collagen activation in human platelets. J. Biol. Chem. 279: 19421-19430.
27. Bills, T. K., J. B. Smith, and M. J. Silver. 1977. Selective release of arachidonic acid from the phospholipids of human platelets in response to thrombin. J. Clin. Invest. 60: 1-6.
28. 2. J. Biol. Chem. 266: 7227-7232.
29. Blockmans, D., H. Deckmyn, and J. Vermylen. 1995. Platelet activation. Blood Rev. 9: 143-156.
30. 2 regulation of arachidonic acid mobilization. FEBS Lett. 531: 2-6.
31. 2 cascade in hydroperoxide-stressed platelets. Free Radic. Biol. Med. 35: 616-625.
32. 2 as a therapeutic target. Biochim. Biophys. Acta. 1488: 182-187.
33. 2 in activated platelets. Thromb. Res. 92: 19-26.
34. Bevers, E. M., P. Comfurius, D. W. Dekkers, and R. F. Zwaal. 1999. Lipid translocation across the plasma membrane of mammalian cells. Biochim. Biophys. Acta. 1439: 317-330.
35. Sims, P. J., and T. Wiedmer. 2001. Unraveling the mysteries of phospholipids scrambling. Thromb. Haemost. 86: 266-275.